Article

(2025) Editorial Expression of Concern: The potential use of nanozymes as an antibacterial agents in oral infection, periodontitis, and peri-implantitis. Journal of Nanobiotechnology. p. 1.

(2025) Editorial Expression of Concern: The potential use of nanozymes as an antibacterial agents in oral infection, periodontitis, and peri-implantitis(Journal of Nanobiotechnology, (2024), 22, (1), 10.1186/s12951-024-02472-x). Journal of Nanobiotechnology. ISSN 14773155 (ISSN)

(2025) Erratum: Editorial Expression of Concern: The potential use of nanozymes as an antibacterial agents in oral infection, periodontitis, and peri-implantitis (Journal of nanobiotechnology). Journal of Nanobiotechnology. p. 327. ISSN 14773155 (ISSN)

(2024) The potential use of nanozymes as an antibacterial agents in oral infection, periodontitis, and peri-implantitis (Publication with Expression of Concern. See vol. 23, 2025). Journal of Nanobiotechnology. p. 35.

(2024) The potential use of nanozymes as an antibacterial agents in oral infection, periodontitis, and peri-implantitis. Journal of Nanobiotechnology. p. 35.

(2023) MicroRNAs Function in Dental Stem Cells as a Promising Biomarker and Therapeutic Target for Dental Diseases. Molecular Diagnosis & Therapy. pp. 703-722. ISSN 1177-1062

(2022) Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. Virology Journal.

(2022) A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. International Journal of Pharmaceutics.